Creating a compliant and scalable CGT logistics launch plan

As cell and gene therapies (CGTs) move from clinical trials to commercial launches, biopharmaceutical companies need to address complex logistical challenges with a strategy that’s customized to their product. Assessing their product’s requirements — such as for temperature controls and regulatory compliance — will ensure a smoother end-to-end delivery and help avoid supply chain disruptions.

The logistics decisions that you need to make when commercializing your cell or gene therapy are complex. Read six expert tips for handling them — from cryogenic shipping to biohazard disposal.